Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | VIVS VivoSim Labs, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $0.21 +3.5% | $15.90 +3.6% |
| StockIQ Score | 41D Weak Risk: High | 41D Weak Risk: High |
| Technical | 23F | 36F |
| Fundamental | 47D+ | 35F |
| Growth | 26F | 50C- |
| Fair Value | 50C- | 38F |
| News | 86A | 50C- |
| Quality | 42D | 50C- |
| Risk | 40D | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
VivoSim Labs (VIVS) scores higher in fundamental (47 vs. 35) and valuation (50 vs. 38) metrics, suggesting stronger financial health and pricing relative to its peers. Ascentage Pharma (AAPG) leads in growth (50 vs. 26), indicating faster expected expansion. Both carry a "WEAK" rating, but AAPG’s technical score (36 vs. 23) shows slightly better short-term trading strength.
